Block Jb
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
-
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
Papers in
-
- Cancer therapeutics and mechanisms 2
- Metabolism, Diabetes, and Cancer 1
- Oncology 4
- Cancer Treatment and Pharmacology 2
- Vascular Tumors and Angiosarcomas 1
- Co-authors
- Guarino Am (1 shared paper)Oliverio Vt (1 shared paper)Gottlieb Ja (1 shared paper)Chlebowski Rt (3 shared papers)Mark Tong (1 shared paper)Chan Kk (1 shared paper)Steven A. Akman (1 shared paper)Martin Dietrich (1 shared paper)
- Journals
- PubMed (11 papers)
In The Last Decade
Block Jb
11 papers receiving 378 citations
Peers
Comparison fields: 5 of 69
- Toxicology 47
- Oncology 212
- Hepatology 59
- Molecular Biology 262
- Neurology 36
Countries citing papers authored by Block Jb
This map shows the geographic impact of Block Jb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Block Jb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Block Jb more than expected).
Fields of papers citing papers by Block Jb
This network shows the impact of papers produced by Block Jb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Block Jb. The network helps show where Block Jb may publish in the future.
Co-authors
The 11 scholars most cited alongside Block Jb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880). | 1970 | 227 |
| 2 | Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results. | 1984 | 81 |
| 3 | Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation. | 1985 | 46 |
| 4 | Doxorubicin cytotoxicity enhanced by local anesthetics in a human melanoma cell line. | 1982 | 26 |
| 5 | Preliminary observations on temperature-enhanced drug uptake by leukemic leukocytes in vitro. | 1976 | 10 |
| 6 | Influence of serum protein binding on renal clearance of I 131-labeled diodrast. | 1960 | 7 |
| 7 | Amphotericin B effects in tissue culture cell lines. | 1979 | 6 |
| 8 | Effects of carrier diodrast on excretion of I 131-labeled diodrast. | 1960 | 5 |
| 9 | RENAL TUBULAR REABSORPTION DEFECTS ASSOCIATED WITH ISOPHTHALANILIDE (NSC-53212). | 1964 | 3 |
| 10 | Vinyl chloride and angiosarcoma. | 1974 | 3 |
| 11 | Immunotherapy for leukemia: quantitative aspects and adjuvant relationships to chemotherapy. | 1969 | 2 |
About Block Jb
Block Jb is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pharmacology, having authored 11 papers that have together received 416 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer therapeutics and mechanisms (2 papers), Nanoplatforms for cancer theranostics (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Vascular Tumors and Angiosarcomas (1 paper), Prostate Cancer Treatment and Research (1 paper) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Toxicology (47 citations), Oncology (212 citations), Hepatology (59 citations), Molecular Biology (262 citations) and Neurology (36 citations). Frequent co-authors include Guarino Am, Oliverio Vt, Gottlieb Ja, Chlebowski Rt, Mark Tong, Chan Kk, Steven A. Akman, Martin Dietrich, David K Cundiff and Marilyn A. Dietrich. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.